Related Experiment Video
Updated: Jul 2, 2026
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Glycodelin reduces breast cancer xenograft growth in vivo
Laura C Hautala1, Riitta Koistinen, Markku Seppälä
1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Abstract:
Malignant growth is characterized by loss of cell differentiation, uncontrolled proliferation and resistance to apoptosis. Many tumor suppressor genes that protect cells against malignant transformation regulate cell differentiation. Here, we show for the first time that glycodelin, a differentiation-related protein, reduces breast cancer tumor growth in vivo. We found that glycodelin cDNA-transfected MCF-7 breast cancer cells showed a differentiated phenotype and produced smaller tumors in mouse mammary fat pads compared with control-transfected cells. Glycodelin-induced differentiation was associated with reduced expression of oncogenes and increased expression of tumor suppressor genes. Our results suggest that glycodelin acts as a tumor suppressor in breast cancer. This may explain its reported association with a more favorable prognosis in some cancers.
Insights
Glycodelin, a differentiation-related protein, was found to reduce breast cancer tumor growth. This protein suppressed tumor development by promoting cell differentiation and altering oncogene and tumor suppressor gene expression, acting as a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Malignant growth involves loss of cell differentiation, uncontrolled proliferation, and apoptosis resistance.
- Tumor suppressor genes regulate cell differentiation and protect against malignant transformation.
Purpose of the Study:
- To investigate the role of glycodelin, a differentiation-related protein, in breast cancer tumor growth.
- To determine if glycodelin exhibits tumor suppressor activity in breast cancer models.
Main Methods:
- Transfection of MCF-7 breast cancer cells with glycodelin cDNA.
- In vivo tumor growth assessment in mouse mammary fat pads.
- Analysis of oncogene and tumor suppressor gene expression.
Main Results:
- Glycodelin cDNA-transfected cells exhibited a differentiated phenotype.
- Transfected cells produced smaller tumors compared to controls.
- Glycodelin induced differentiation was linked to decreased oncogene and increased tumor suppressor gene expression.
Conclusions:
- Glycodelin functions as a tumor suppressor in breast cancer.
- The findings support glycodelin's association with a favorable prognosis in certain cancers.
More Related Videos
13:43Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
06:06High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
Published on: December 20, 2024